Reduced serum levels of apoA2 isoforms, especially apoA2-ATQ/AT and reduced specific apoA2 isoform hypo-processing patterns, have been proposed as useful in differentiating disease activity in AIP and could aid the differentiation between AIP and pancreatic cancer [53]. The gene discussed is APOA2; the disease is pancreatic neoplasm.